Irinotecan in Combination With Cisplatin in Pediatric Patients With Unfavorable Prognosis Gliomas

NCT01574092 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

39

Enrollment

OTHER

Sponsor class

Conditions

Pediatric High Risk Gliomas

Interventions

DRUG: Combination of two marketed drugs (irinotecan and cisplatin)

Sponsor

Hospital Sant Joan de Deu

Collaborators

[object Object]
[object Object]